Choose your region

Select the region that best fits your location or preferences.

Choose your site language

This setting controls the language of the user interface, including buttons, menus, and all site text. Select your preferred language for the best browsing experience.

Choose your job languages

Select the languages for job listings you want to see. This setting determines which job advertisements will be displayed to you.

DIACCURATE

DIACCURATE

Visit website

About the employer

Diaccurate is a spin off from the Pasteur Institute in Paris, France. We work on a new enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. Involvement of this mechanism in the control of tumor growth is also under study. We have discovered in the plasma of immunodeficient patients, a new molecule named RIF (for “Refractory state Inducing Factor”) which by modifying their membrane blocks specifically CD4 lymphocytes responses. Inhibitory monoclonal antibody neutralizing RIF has been characterized and clinical trials should start in 2018.

Employer location

Discover similar employers